T. Inaba

6.1k total citations · 1 hit paper
122 papers, 5.2k citations indexed

About

T. Inaba is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, T. Inaba has authored 122 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pharmacology, 25 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in T. Inaba's work include Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (24 papers) and Metabolism and Genetic Disorders (23 papers). T. Inaba is often cited by papers focused on Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (24 papers) and Metabolism and Genetic Disorders (23 papers). T. Inaba collaborates with scholars based in Canada, Japan and United States. T. Inaba's co-authors include W. Kalow, S V Otton, W Kalow, Rachel F. Tyndale, David J. Stewart, M Jurima, Frank J. Gonzalez, Edward M. Sellers, Harry V. Gelboin and Urs Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

T. Inaba

120 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver

1989 434 citations Rachel F. Tyndale, T. Inaba et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Inaba Canada	37	2.7k	1.3k	1.0k	899	778	122	5.2k
Felix Bochner Australia	42	1.3k 0.5×	826 0.6×	710 0.7×	1.2k 1.3×	1.1k 1.4×	162	5.3k
M. S. Lennard United Kingdom	36	2.4k 0.9×	1.1k 0.8×	774 0.7×	847 0.9×	421 0.5×	114	4.6k
Juliette Säwe Sweden	37	1.5k 0.6×	664 0.5×	555 0.5×	602 0.7×	1.4k 1.8×	77	4.5k
David E. Moody United States	41	1.1k 0.4×	516 0.4×	1.5k 1.4×	714 0.8×	779 1.0×	192	5.5k
Geoffrey T. Tucker United Kingdom	58	4.9k 1.8×	2.8k 2.1×	1.8k 1.8×	1.8k 2.0×	2.0k 2.6×	190	12.0k
Takashi Ishizaki Japan	54	4.0k 1.5×	2.2k 1.7×	1.7k 1.7×	1.3k 1.4×	1.4k 1.8×	296	10.0k
Tatsuji Iga Japan	39	1.6k 0.6×	1.8k 1.4×	1.4k 1.4×	1.1k 1.2×	830 1.1×	340	5.8k
W. Kalow Canada	57	4.0k 1.5×	1.6k 1.2×	3.2k 3.1×	2.9k 3.2×	1.2k 1.6×	237	11.1k
Kan Chiba Japan	41	2.8k 1.0×	2.0k 1.6×	1.6k 1.5×	1.0k 1.2×	891 1.1×	158	7.2k
David G. Shand United States	53	2.2k 0.8×	1.3k 1.0×	1.6k 1.6×	2.1k 2.4×	962 1.2×	150	10.6k

Countries citing papers authored by T. Inaba

Since Specialization

Citations

This map shows the geographic impact of T. Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Inaba more than expected).

Fields of papers citing papers by T. Inaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Inaba. The network helps show where T. Inaba may publish in the future.

Co-authorship network of co-authors of T. Inaba

This figure shows the co-authorship network connecting the top 25 collaborators of T. Inaba. A scholar is included among the top collaborators of T. Inaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Inaba. T. Inaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuen, Shuichi, Tsuyoshi Fukuda, Yuka Ikenaga, et al.. (2002). Novel detection assay by PCR???RFLP and frequency of the CYP3A5 SNPs, CYP3A5 *3 and *6, in a Japanese population. Pharmacogenetics. 12(4). 331–334. 155 indexed citations

Fukuen, Shuichi, Tsuyoshi Fukuda, Hideyasu Matsuda, et al.. (2002). Identification of the novel splicing variants for the hPXR in human livers. Biochemical and Biophysical Research Communications. 298(3). 433–438. 53 indexed citations

Fukuda, Tsuyoshi, et al.. (1999). Relationship between mRNA Levels Quantified by Reverse Transcription-Competitive PCR and Metabolic Activity of CYP3A4 and CYP2E1 in Human Liver. Biochemical and Biophysical Research Communications. 262(2). 499–503. 75 indexed citations

Inaba, T., et al.. (1997). Estimation of the human hepatic microsomal cytochrome P-450 species responsible to the thrmieihadione metabolism. The Japanese Journal of Pharmacology. 73. 115–115. 4 indexed citations

Otton, S V, S. Ball, Siu Wah Cheung, et al.. (1996). Venlafaxine oxidationin vitrois catalysed by CYP2D6. British Journal of Clinical Pharmacology. 41(2). 149–156. 189 indexed citations

Wu, Di, S V Otton, Paul E. Morrow, et al.. (1993). Human hepatic cytochrome P450 2D6-like activity in nonhuman primates: catalytic characterization in vitro.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 715–719. 21 indexed citations

Sasa, Hidenori, T. Inaba, Chikako Tanaka, So Tokunaga, & Yoshinobu Wakisaka. (1990). Study on thymic remnant in the neck in rats: Effects of 6-aminonicotinamide on the incidence in rat fetuses : Abstracts of Papers Presented at the Thirtieth Annual Meeting of the Japanese Teratology Society Miyazaki, Japan, July 12-13, 1990. Congenital Anomalies. 30(3). 255–256. 1 indexed citations

Muralidharan, G., K.K. Midha, G. McKay, E. M. Hawes, & T. Inaba. (1989). Selectivein vivoinhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism. Xenobiotica. 19(2). 189–197. 11 indexed citations

Tyndale, Rachel F., T. Inaba, & W Kalow. (1989). Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitro.. Drug Metabolism and Disposition. 17(3). 334–340. 25 indexed citations

10.

Inaba, T., W. Kalow, Toshiyuki Someya, et al.. (1989). Haloperidol reduction can be assayed in human red blood cells. Canadian Journal of Physiology and Pharmacology. 67(11). 1468–1469. 26 indexed citations

11.

Inaba, T., Alan R. Tait, Masahiro Nakano, W. A. Mahon, & W Kalow. (1988). Metabolism of diazepam in vitro by human liver. Independent variability of N-demethylation and C3-hydroxylation.. Drug Metabolism and Disposition. 16(4). 605–608. 31 indexed citations

12.

Inaba, T., et al.. (1988). A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: A case of genetic divergence with tentative phylogenetic time frame for the pathway. Clinical Pharmacology & Therapeutics. 44(3). 343–352. 12 indexed citations

13.

Inaba, T., et al.. (1983). Human metabolism of antipyrine labelled with¹⁴C in the pyrazolone ring or in the N-methyl group. Xenobiotica. 13(3). 155–162. 17 indexed citations

14.

Inaba, T., Alexander A. Vinks, S V Otton, & W. Kalow. (1983). Comparative pharmacogenetics of sparteine and debrisoquine. Clinical Pharmacology & Therapeutics. 33(3). 394–399. 33 indexed citations

15.

Inaba, T., Haruto Uchino, D. Kadar, & W. Kalow. (1981). Antipyrine metabolites in two populations.. PubMed. 32(2). 235–44. 5 indexed citations

16.

Tang, B., T. Inaba, & W. Kalow. (1977). N-Hydroxylation of pentobarbital in man.. Drug Metabolism and Disposition. 5(1). 71–74. 13 indexed citations

17.

Mahon, W. A., et al.. (1976). Biliary elimination of diazepam in man. Clinical Pharmacology & Therapeutics. 19(4). 443–450. 22 indexed citations

18.

Mahon, W. A., Michael Mayersohn, & T. Inaba. (1976). Disposition kinetics of two oral forms of quinidine. Clinical Pharmacology & Therapeutics. 19(5part1). 566–575. 30 indexed citations

19.

Inaba, T. & W. Kalow. (1975). Salivary excretion of amobarbital in man. Clinical Pharmacology & Therapeutics. 18(5part1). 558–562. 32 indexed citations

20.

Brien, James F. & T. Inaba. (1974). Determination of low levels of 5,5-diphenylhydantoin in serum by gas-liquid chromatography. Journal of Chromatography A. 88(2). 265–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact